Operating Lease, Payments in USD of Tvardi Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2021 to Q3 2025.
  • Tvardi Therapeutics, Inc. Operating Lease, Payments for the quarter ending 30 Sep 2025 was $50K, unchanged year-over-year.
  • Tvardi Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $4.36M, a 119% increase from 2023.
  • Tvardi Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.99M, a 1.79% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $50K $0 0% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $50K +$1K +2.04% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q3 2024 $50K -$450K -90% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $49K -$447K -90.1% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q4 2023 $1.99M $502K +$8K +1.62% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $1.98M $500K +$9K +1.83% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $1.98M $496K +$9K +1.85% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $1.97M $494K +$9K +1.86% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $1.96M $494K 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $491K +$9K +1.87% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $487K +$9K +1.88% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $485K +$9K +1.89% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q3 2021 $482K 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $478K 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 $476K 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022

Tvardi Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.36M +$2.37M +119% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 $1.99M +$35K +1.79% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 $1.96M 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.